Peripheral lines a central element of infection risk reduction
According to a recent survey of 650 U.S. infection preventionists and clinicians, more than 50 percent of those surveyed strongly agreed that peripheral line associated bloodstream infection (PLABSI) poses a real threat to patients in acute care settings.
In an effort to address these growing concerns, 3M™ has introduced 3M™ Tegaderm™ Antimicrobial I.V. Advanced Securement Dressing and 3M™ Tegaderm™ Antimicrobial Transparent Dressing to enhance its offerings for PIV maintenance solutions.
Research shows that up to 47 percent of central-line associated bloodstream infection (CLABSI) occurred in patients with multiple lines, including PIV lines. Contamination at the PIV insertion site can be a source of bloodstream infections. For example, the leading source of healthcare-acquired S. aureus bloodstream infections in one hospital over an 8-year period was associated with PIVs. More broadly, research shows viable bacteria may remain on the skin, and regrowth may occur within 24 hours after the use of chlorhexidine gluconate (CHG) skin preps.
“Successful infection prevention relies on clinicians using proven technology in alignment with best practice protocols,” stated Pat Parks, MD, PhD, medical director for 3M Medical Solutions Division. “The new Tegaderm Antimicrobial I.V. Securement Dressing helps enable clinicians to provide antimicrobial protection for patients with PIV lines and helps make PIV lines a central part of infection risk reduction programs.”